JTC Employer Solutions Trustee’s Xenetic Biosciences XBIO Stock Holding History

JTC Employer Solutions Trustee’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8K	Hold	2,700	–	–	﹤0.01%	292
2026 Q1	$7K	Hold	2,700	–	–	﹤0.01%	284
2025 Q4	$6K	Hold	2,700	–	–	﹤0.01%	291
2025 Q3	$9K	Hold	2,700	–	–	﹤0.01%	285
2025 Q2	$11K	Hold	2,700	–	–	﹤0.01%	276
2025 Q1	$7K	Hold	2,700	–	–	﹤0.01%	289
2024 Q4	$11K	Hold	2,700	–	–	﹤0.01%	287
2024 Q3	$12K	Hold	2,700	–	–	﹤0.01%	297
2024 Q2	$11K	Hold	2,700	–	–	﹤0.01%	299
2024 Q1	$10K	Hold	2,700	–	–	﹤0.01%	308
2023 Q4	$10K	Hold	2,700	–	–	﹤0.01%	311
2023 Q3	$8K	Hold	2,700	–	–	﹤0.01%	321
2023 Q2	$9K	Buy	2,700 +1	+0%	+$4	﹤0.01%	328
2023 Q1	$11K	Hold	2,699	–	–	﹤0.01%	331
2022 Q4	$8K	Hold	2,699	–	–	﹤0.01%	358
2022 Q3	$15K	Hold	2,699	–	–	﹤0.01%	270
2022 Q2	$21K	Hold	2,699	–	–	﹤0.01%	236
2022 Q1	$28K	Hold	2,699	–	–	﹤0.01%	237
2021 Q4	$35K	Hold	2,699	–	–	﹤0.01%	230
2021 Q3	$57K	Hold	2,699	–	–	0.01%	206
2021 Q2	$55K	Buy	+2,699	New	+$54.4K	0.01%	208

Other funds holding XBIO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DWM

Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

JTC Employer Solutions Trustee's XBIO Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Xenetic Biosciences (XBIO) position steady in Q2 2026 at 2,700 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #292.

JTC Employer Solutions Trustee first reported a position in XBIO in Q2 2021 and has held it in 21 quarters since. The position peaked at $57K in Q3 2021. 8 funds tracked by Wall St. Rank hold XBIO as of Q2 2026.

JTC Employer Solutions Trustee held 2,700 shares of Xenetic Biosciences worth $8K as of Q2 2026.
JTC Employer Solutions Trustee left its Xenetic Biosciences share count unchanged in Q2 2026.
Xenetic Biosciences made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #292 holding.
JTC Employer Solutions Trustee first reported a position in Xenetic Biosciences in Q2 2021 and has held it in 21 quarters since.
JTC Employer Solutions Trustee's Xenetic Biosciences position peaked at $57K in Q3 2021.
8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.